RKDA Arcadia Biosciences
- 4.0800
- -0.0800-1.92%
Arcadia Biosciences News
Arcadia Biosciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Arcadia Biosciences (RKDA)
H.C. Wainwright Maintains Arcadia Biosciences(RKDA.US) With Buy Rating, Maintains Target Price $6
Lake Street Maintains Arcadia Biosciences(RKDA.US) With Buy Rating, Maintains Target Price $12
Arcadia Biosciences Analyst Ratings
Lake Street Reaffirms Their Buy Rating on Arcadia Biosciences (RKDA)
Buy Rating on Arcadia Biosciences Fueled by Strategic Initiatives and Innovative Product Launches
Arcadia Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $10 Price Target
Buy Rating Affirmed for Arcadia Biosciences Amidst Growth and Strategic Shifts
Analysts Have Conflicting Sentiments on These Healthcare Companies: Rain Therapeutics (RAIN), Arcadia Biosciences (RKDA) and Eiger Biopharmaceuticals (EIGR)
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $10
Arcadia Biosciences Analyst Ratings
H.C. Wainwright Sticks to Its Buy Rating for Arcadia Biosciences (RKDA)
HC Wainwright & Co. Reiterates Buy on Arcadia Biosciences, Maintains $15 Price Target
Arcadia Biosciences Analyst Ratings
HC Wainwright Adjusts Price Target on Arcadia Biosciences to $15 From $18, Keeps Buy Rating
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $15
HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Raises Price Target to $18
Analysts Offer Insights on Materials Companies: Gold Resource (GORO) and Arcadia Biosciences (RKDA)
Analysis
Price Target
No Data
No Data
